Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sarcoma | 6 | 2023 | 1898 | 1.170 |
Why?
|
Radiation Tolerance | 2 | 2019 | 486 | 1.140 |
Why?
|
Hypopituitarism | 1 | 2023 | 254 | 0.780 |
Why?
|
Therapies, Investigational | 1 | 2018 | 112 | 0.590 |
Why?
|
Biological Assay | 1 | 2019 | 650 | 0.530 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1345 | 0.490 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 3 | 2013 | 834 | 0.440 |
Why?
|
Propionates | 1 | 2013 | 169 | 0.430 |
Why?
|
Radiotherapy | 2 | 2019 | 1533 | 0.430 |
Why?
|
Neuroprotective Agents | 3 | 2013 | 941 | 0.410 |
Why?
|
Tumor Microenvironment | 2 | 2020 | 3583 | 0.400 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2177 | 0.360 |
Why?
|
Neoplasms | 4 | 2024 | 21675 | 0.340 |
Why?
|
Soft Tissue Neoplasms | 1 | 2018 | 1363 | 0.320 |
Why?
|
Nitriles | 1 | 2013 | 953 | 0.310 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2019 | 2018 | 0.290 |
Why?
|
Neutrophils | 1 | 2019 | 3718 | 0.290 |
Why?
|
Immunotherapy | 5 | 2024 | 4437 | 0.280 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2190 | 0.250 |
Why?
|
Herpesviridae | 1 | 2023 | 109 | 0.220 |
Why?
|
Toll-Like Receptor 3 | 1 | 2022 | 90 | 0.210 |
Why?
|
Protein Kinase Inhibitors | 1 | 2018 | 5532 | 0.200 |
Why?
|
Combined Modality Therapy | 3 | 2024 | 8637 | 0.190 |
Why?
|
DNA Polymerase II | 1 | 2020 | 107 | 0.180 |
Why?
|
Rationalization | 1 | 2018 | 6 | 0.160 |
Why?
|
Whole-Body Irradiation | 1 | 2019 | 449 | 0.160 |
Why?
|
Sarcoma, Experimental | 1 | 2018 | 128 | 0.160 |
Why?
|
Estrogen Receptor alpha | 2 | 2013 | 577 | 0.160 |
Why?
|
Mice, Inbred Strains | 1 | 2020 | 1826 | 0.160 |
Why?
|
Tumor Escape | 1 | 2020 | 350 | 0.150 |
Why?
|
Fatigue | 1 | 2023 | 1530 | 0.140 |
Why?
|
Cell Tracking | 1 | 2017 | 144 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2019 | 1588 | 0.130 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2019 | 547 | 0.130 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1272 | 0.120 |
Why?
|
Demyelinating Diseases | 2 | 2013 | 354 | 0.120 |
Why?
|
Oncogenes | 1 | 2019 | 1265 | 0.110 |
Why?
|
Freund's Adjuvant | 1 | 2013 | 139 | 0.110 |
Why?
|
Gold | 1 | 2017 | 485 | 0.110 |
Why?
|
Mice | 9 | 2023 | 81154 | 0.110 |
Why?
|
Staining and Labeling | 1 | 2017 | 1098 | 0.110 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2764 | 0.110 |
Why?
|
Estrogen Receptor beta | 1 | 2013 | 175 | 0.110 |
Why?
|
Nanostructures | 1 | 2017 | 552 | 0.100 |
Why?
|
Animals | 10 | 2023 | 168660 | 0.100 |
Why?
|
Carotid Stenosis | 1 | 2018 | 854 | 0.090 |
Why?
|
Adipocytes | 1 | 2017 | 1182 | 0.090 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6895 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6539 | 0.080 |
Why?
|
Astrocytes | 2 | 2013 | 1273 | 0.080 |
Why?
|
Axons | 2 | 2013 | 1685 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18027 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2020 | 4477 | 0.070 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9731 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Medical Oncology | 1 | 2018 | 2267 | 0.070 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2018 | 876 | 0.070 |
Why?
|
Estrogens | 1 | 2013 | 1563 | 0.070 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5170 | 0.070 |
Why?
|
Adipose Tissue | 1 | 2017 | 3280 | 0.060 |
Why?
|
Humans | 11 | 2024 | 743811 | 0.060 |
Why?
|
Treatment Outcome | 2 | 2023 | 63042 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2020 | 8430 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2018 | 2736 | 0.060 |
Why?
|
Stem Cells | 1 | 2017 | 3566 | 0.060 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9648 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2281 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2018 | 10477 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 12788 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2023 | 220 | 0.050 |
Why?
|
Melanoma | 1 | 2019 | 5508 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2013 | 5096 | 0.050 |
Why?
|
Middle Aged | 4 | 2023 | 213241 | 0.050 |
Why?
|
Methylcholanthrene | 1 | 2019 | 29 | 0.040 |
Why?
|
Mice, Inbred C57BL | 2 | 2013 | 21824 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2019 | 57744 | 0.040 |
Why?
|
Carcinogens | 1 | 2019 | 466 | 0.040 |
Why?
|
Neurons | 2 | 2013 | 9336 | 0.040 |
Why?
|
Relative Biological Effectiveness | 1 | 2018 | 323 | 0.030 |
Why?
|
Retrospective Studies | 3 | 2019 | 77410 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29777 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23398 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2570 | 0.030 |
Why?
|
Severity of Illness Index | 1 | 2013 | 15526 | 0.030 |
Why?
|
Genomic Instability | 1 | 2019 | 695 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2017 | 249 | 0.030 |
Why?
|
Chemokine CCL7 | 1 | 2013 | 27 | 0.030 |
Why?
|
Young Adult | 1 | 2019 | 56392 | 0.030 |
Why?
|
Female | 5 | 2019 | 380020 | 0.030 |
Why?
|
Aged | 3 | 2019 | 163178 | 0.030 |
Why?
|
Radiometry | 1 | 2018 | 800 | 0.030 |
Why?
|
Gliosis | 1 | 2013 | 245 | 0.030 |
Why?
|
Aquaporin 4 | 1 | 2013 | 153 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1691 | 0.030 |
Why?
|
Immunity, Innate | 1 | 2023 | 2961 | 0.020 |
Why?
|
Adolescent | 1 | 2019 | 85729 | 0.020 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 620 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2019 | 4183 | 0.020 |
Why?
|
Cell Count | 1 | 2013 | 1855 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6311 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2944 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2017 | 19232 | 0.020 |
Why?
|
Adult | 2 | 2019 | 213889 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1962 | 0.020 |
Why?
|
Mice, Knockout | 2 | 2013 | 14563 | 0.020 |
Why?
|
Spinal Cord | 1 | 2013 | 1809 | 0.020 |
Why?
|
Ligands | 1 | 2011 | 3281 | 0.010 |
Why?
|
Neurodegenerative Diseases | 1 | 2011 | 1060 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9718 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11478 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11360 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29052 | 0.010 |
Why?
|
Cohort Studies | 1 | 2019 | 40545 | 0.010 |
Why?
|
Male | 3 | 2019 | 349776 | 0.010 |
Why?
|
Inflammation | 1 | 2011 | 10629 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72252 | 0.010 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_